Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Empress Medical is developing fibroid treatment solutions.
The company is focused on changing the standard of care for women worldwide and reducing the number of hysterectomies by introducing an easy-to-use laparoscopic technology designed for gynecologists operating in average settings, making it accessible to more underserved women, delivering on the promise to offer a broader base of women a safe, uterus-preserving fibroid treatment option, and preserving fertility.
The Empress system is intended to treat symptomatic uterine fibroids in a laparoscopic procedure by inducing fibroid tissue ischemia. Sutures wrapped around the fibroid increase the intra-tumoral pressure, which leads to fibroid ischemia — blockage of intra- and peri-fibroid blood flow — and, eventually, necrosis of the fibroid tissue.